New York/London, 27 November 2013 – Traiana, the leading provider of pre-trade risk and post-trade processing solutions, announces that it has launched a comprehensive Unique Trade Identifier (UTI) management solution using the Harmony network.
As each jurisdiction introduces its own specific trade reporting requirements and UTI methodology, the management and sharing of trade identifiers with counterparts is becoming more complex.
The Traiana UTI management service facilitates the exchange of UTIs between counterparts, thereby allowing both parties to a trade to report using a common trade identifier, to the same or different trade repositories.
Reporting using the same trade identifier is the responsibility of both sides of the trade and is a cornerstone of EMIR trade reporting; the Traiana solution provides a flexible and scalable mechanism to fulfill this requirement.
Roy Saadon, Co-Founder, Traiana said: “In speaking to our client base it has become clear that the most pressing issue is to manage UTIs across all regulatory reporting jurisdictions so that both parties to a trade can meet their reporting obligations in the required timeline.”
Andy Coyne, CEO, Traiana commented: “As part of our suite of regulatory reporting solutions, we are pleased to be in a position to provide a comprehensive UTI sharing and management solution, using the Harmony network.”
The service provides a true cross-asset platform for UTI management across jurisdictions in order to address the full market need and offer real market efficiencies.
Traiana, Inc. (www.traiana.com) provides global banks, broker/dealers, buy-side firms and trading platforms with services to monitor pre- trade risk and automate post-trade processing of financial transactions in listed and over-the-counter trading markets. Traiana’s solutions and the Harmony Network have become the market standard for post-trade processing of foreign exchange, exchange traded derivatives, fixed income, CDS and synthetic and cash equity transactions. Traiana, an ICAP company, is headquartered in New York City with offices in Chicago, Hong Kong, London, Singapore, Tel Aviv and Tokyo.
Tel: +44 (0) 20 7397 2949